Artificial intelligence in cardiac metabolism: the next frontier in cardiovascular health

In this article, we aim to explore the rapidly developing role of artificial intelligence (AI) in cardiac metabolism research, highlighting its impact on biomarker discovery, precision medicine, and patient stratification. Cardiac metabolism, a key determinant of cardiovascular health, is often disrupted in cardiovascular diseases (CVDs) like heart failure and coronary artery disease. AI's ability to process and analyze large-scale data offers new chances for understanding and addressing these metabolic dysfunctions. By integrating up-to-date technologies with molecular and clinical insights, AI enables the achievement of personalized treatments, more accurate diagnostics, and the discovery of potential novel therapeutic targets. The main challenges include ethical concerns around data privacy, algorithmic bias, and the need for representative datasets. Future directions focus on developing transparent, accountable, and collaborative AI models that integrate data, and enable real-time monitoring, ensuring fairness and accessibility in healthcare. As AI continues to evolve, its role in advancing cardiovascular care is expected to grow, offering new trends in cardiovascular research.